Novel method for generating antibodies could revolutionize Alzheimer’s and Parkinson’s research

In diseases like Parkinson’s and Alzheimer’s, specific proteins misfold and clump together, forming toxic aggregates that damage brain cells.

SYNLAB AG publishes Joint Reasoned Statement on public acquisition offer by Cinven – Biotech Investments

EQS-News: SYNLAB AG / Key word(s): Statement SYNLAB AG publishes Joint Reasoned Statement on public acquisition offer by Cinven 02.11.2023 / 17:46 CET/CEST The issuer

November 3, 2023

Roche ends KRAS deal with Hookipa Pharma, as biotech lays off 30% of staff

Roche is waving goodbye to a KRAS program it partnered on less than a year and a half ago. The Swiss conglomerate ended its collaboration

January 30, 2024

Most cardiovascular devices with serious safety recalls aren’t tested in patients

When someone’s heart doesn’t beat quite right, an implantable defibrillator can save their life. The devices can jump-start a misbehaving heart, resetting its normal rhythm

September 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.